Once-weekly injection with stronger weight loss results in clinical trials
As a safe, effective and convenient novel therapeutic option, mazdutide addresses the critical needs of long-term glucose management and complication prevention in T2D, actively supporting the realization of the "Healthy China 2030" vision
Ongoing trials are now exploring tirzepatide's potential to support ovulation, reduce androgens and improve reproductive outcomes
By week 16, most patients have been on the 0.5mg-1mg dose range for 10-12 weeks, and the results look meaningfully different from the early timeline
[70] Salicylates may have altered serum concentrations when prednisone is discontinued, potentially leading to salicylate toxicity
GLP-1 users tend to: Eat smaller portions